Skip to content

Application value of pressing needle therapy in perioperative anesthesia and analgesia of one-lung ventilation thoracoscopic surgery

Application value of pressing needle therapy in perioperative anesthesia and analgesia of one-lung ventilation thoracoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048410
Enrollment
Unknown
Registered
2021-07-06
Start date
2021-06-30
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Sponsors

Jiangsu Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. At least 18 years old; 2. Planned elective thoracoscopic-assisted radical unilateral lung cancer resection (lobectomy, segmental resection or wedge resection); 3. ASA classification I-III; 4. BMI <30kg/m^2; 5. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Preoperative pulmonary function test indicates severe ventilation or ventilation dysfunction (FVC <80% predicted value or FEV1 <70% predicted value); 2. Complicated with severe liver and kidney insufficiency, autoimmune disease, immunodeficiency disease, or used immunosuppressive therapy within 6 months before surgery; 3. Complicated with chronic obstructive pulmonary disease, asthma, or a history of respiratory tract infection within 1 month.

Design outcomes

Primary

MeasureTime frame
IL-1 alpha;IL-1 beta;TNF-alpha;HIF-1 alpha;Postoperative pain scores during hospitalization;Analgesic use;Incidence of pulmonary complications;

Secondary

MeasureTime frame
The occurrence of adverse events;

Countries

China

Contacts

Public ContactSong Zhenghuan

Jiangsu Cancer Hospital

15952017176@163.com+86 15952017176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026